查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1951853

單細胞分析市場分析及預測（至2035年）：依類型、產品類型、服務、技術、應用、最終用戶、組件、製程及模式分類

Single-cell Analysis Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Process, Mode
出版日期: | 出版商: Global Insight Services | 英文 381 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

單細胞分析市場預計將從2024年的31億美元成長到2034年的110億美元，複合年成長率約為12.7%。單細胞分析市場涵蓋用於分析單一細胞的技術和調查方法，能夠深入了解細胞異質性和微環境。該市場包括儀器、耗材和軟體，可實現單細胞層級的基因組學、轉錄組學和蛋白​​質組學分析。市場成長的驅動力來自對精準醫療日益成長的需求以及生物技術的進步，這些因素共同推動了單細胞分析在腫瘤學、免疫學、幹細胞研究等領域的應用。微流體、定序和生物資訊學的創新正在提升細胞分析的解析度和通量。

受基因組技術和個人化醫療發展趨勢的推動，單細胞分析市場正經歷強勁成長。其中，耗材領域成長最為顯著，這主要得益於單細胞實驗所需試劑和檢測試劑盒的需求。儀器設備，尤其是流式細胞儀和次世代定序平台，緊隨其後，體現了它們在數據收集和分析方面的重要作用。軟體和服務領域也呈現成長勢頭，生物資訊學工具和數據分析服務對於解讀複雜的單細胞數據至關重要。此外，腫瘤學應用也推動了市場成長，這主要源自於對更精準的癌症診斷和治療策略的需求。免疫學應用領域也不斷擴張，印證了免疫分析在疾病研究中的重要性。對單細胞RNA定序的日益關注進一步推動了市場擴張，為深入了解細胞異質性和功能提供了前所未有的視角。

市場區隔
類型 耗材、設備和軟體
產品 試劑、檢測試劑盒、微孔盤、磁珠、設備
服務 細胞分離、單細胞基因體學、單細胞蛋白質體學、單細胞轉錄體學
科技 流式細胞技術、質譜分析、顯微鏡、次世代定序
應用領域 癌症研究、神經學、免疫學、幹細胞研究、微生物學
最終用戶 學術和研究實驗室、生物技術和製藥公司、醫院和診斷實驗室
成分 硬體、軟體和服務
過程 細胞活力評估、細胞鑑定、細胞計數
模式 自動化、手動

單細胞分析市場格局瞬息萬變，大型生技公司佔了相當大的市場。定價策略競爭激烈，反映了該領域的創新性和最尖端科技的不斷湧現。近期推出的產品主要致力於提高精度和擴充性，以滿足日益成長的個人化醫療和先進研究應用需求。在技​​術進步和研發投入不斷增加的推動下，市場正經歷強勁成長。單細胞分析市場的競爭異常激烈，主要參與者透過策略聯盟和創新爭奪主導。監管因素，尤其是在北美和歐洲，包括嚴格的產品品質和安全標準，影響市場動態。基準研究表明，擁有強大研發能力和全面產品系列的公司保持著競爭優勢。在腫瘤學、免疫學和幹細胞研究領域單細胞技術應用日益廣泛的推動下，市場預計將持續成長。儘管監管合規和高昂的營運成本等挑戰依然存在，但醫療保健領域變革性突破的潛力蘊藏著盈利的商機。

主要趨勢和促進因素：

受基因組技術和個人化醫療進步的推動，單細胞分析市場正經歷顯著成長。關鍵趨勢包括人工智慧 (AI) 和機器學習的融合，不僅提升了數據分析和解讀能力，還能更深入地洞察細胞行為。對高通量定序技術的需求也在不斷成長，從而實現更全面、更經濟高效的單細胞研究。推動該市場發展的因素包括慢性病發病率的上升以及對個人化治療方案的需求。研究人員致力於在細胞層面闡明疾病機制，這推動了單細胞分析在腫瘤學和免疫學領域的應用。此外，政府資助和私人投資正在加速研發活動，促進該領域的創新。學術機構和產業界之間的合作也在迅速增加，以將研究成果轉化為臨床應用。在醫療基礎設施不斷改善、研究活動日益活躍的發展中地區，也湧現新的機會。能夠提供擴充性且易於使用的解決方案的公司，預計將佔據可觀的市場佔有率。人們對精準醫療和疾病早期檢測的興趣日益濃厚，這進一步支撐了單細胞分析市場的持續成長潛力。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 消耗品
    • 裝置
    • 軟體
  • 市場規模及預測：依產品分類
    • 試劑
    • 檢測試劑盒
    • 微孔盤
    • 珠
    • 裝置
  • 市場規模及預測：依服務分類
    • 細胞分離
    • 單細胞基因體學
    • 單細胞蛋白質體學
    • 單細胞轉錄組學
  • 市場規模及預測：依技術分類
    • 流式細胞技術
    • 質譜分析
    • 顯微鏡
    • 次世代定序
  • 市場規模及預測：依應用領域分類
    • 癌症研究
    • 神經病學
    • 免疫學
    • 幹細胞研究
    • 微生物學
  • 市場規模及預測：依最終用戶分類
    • 學術與研究機構
    • 生物技術和製藥公司
    • 醫院和診斷檢查室
  • 市場規模及預測：依組件分類
    • 硬體
    • 軟體
    • 服務
  • 市場規模及預測：依製程分類
    • 細胞活力評估
    • 細胞鑑定
    • 細胞計數
  • 市場規模及預測：按模式
    • 自動化
    • 手動的

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Fluidigm
  • 10x Genomics
  • Mission Bio
  • Bio-Rad Laboratories
  • Takara Bio
  • Nano String Technologies
  • Illumina
  • BD Biosciences
  • Berkeley Lights
  • Cytek Biosciences
  • S2 Genomics
  • Epicypher
  • Dolomite Bio
  • Fluxion Biosciences
  • Celsee
  • Rare Cyte
  • Akoya Biosciences
  • Menarini Silicon Biosystems
  • Parse Biosciences
  • Proteona

第9章：關於我們

簡介目錄
Product Code: GIS20532

Single-cell Analysis Market is anticipated to expand from $3.1 billion in 2024 to $11.0 billion by 2034, growing at a CAGR of approximately 12.7%. The Single-cell Analysis Market encompasses technologies and methodologies for examining individual cells, providing insights into cellular heterogeneity and microenvironments. This market includes instruments, consumables, and software that facilitate genomic, transcriptomic, and proteomic analyses at the single-cell level. Rising demand for precision medicine and advancements in biotechnology are propelling growth, with applications in oncology, immunology, and stem cell research. The market is characterized by innovations in microfluidics, sequencing technologies, and bioinformatics, driving enhanced resolution and throughput in cellular analysis.

The Single-cell Analysis Market is experiencing robust growth, propelled by advancements in genomic technologies and personalized medicine. Within this market, the consumables segment emerges as the top-performing category, with reagents and assay kits driving significant demand due to their essential role in single-cell experiments. Instruments, particularly flow cytometers and next-generation sequencing platforms, follow closely, reflecting their critical function in data acquisition and analysis. The software and services segment is gaining momentum, with bioinformatics tools and data analytics services becoming increasingly indispensable for interpreting complex single-cell data. Additionally, the oncology application segment leads in performance, driven by the need for precise cancer diagnostics and treatment strategies. Immunology applications are also on the rise, underscoring the importance of immune profiling in disease research. The growing emphasis on single-cell RNA sequencing further fuels market expansion, offering unparalleled insights into cellular heterogeneity and function.

Market Segmentation
TypeConsumables, Instruments, Software
ProductReagents, Assay Kits, Microplates, Beads, Instruments
ServicesCell Isolation, Single-cell Genomics, Single-cell Proteomics, Single-cell Transcriptomics
TechnologyFlow Cytometry, Mass Spectrometry, Microscopy, Next-generation Sequencing
ApplicationCancer Research, Neurology, Immunology, Stem Cell Research, Microbiology
End UserAcademic & Research Laboratories, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories
ComponentHardware, Software, Services
ProcessCell Viability Assessment, Cell Identification, Cell Counting
ModeAutomated, Manual

The Single-cell Analysis Market is characterized by a dynamic landscape, with significant market share held by leading biotechnology firms. Pricing strategies are competitive, reflecting the innovative nature of the sector and the introduction of new, cutting-edge technologies. Recent product launches have focused on enhancing precision and scalability, catering to the growing demand for personalized medicine and advanced research applications. The market is witnessing robust growth, driven by technological advancements and increased investment in research and development. Competition within the Single-cell Analysis Market is intense, with key players vying for dominance through strategic alliances and innovation. Regulatory influences, particularly in North America and Europe, shape market dynamics by setting stringent standards for product quality and safety. Benchmarking reveals that companies with strong R&D capabilities and comprehensive product portfolios maintain a competitive edge. The market is poised for continued expansion, propelled by the increasing adoption of single-cell technologies in oncology, immunology, and stem cell research. Challenges such as regulatory compliance and high operational costs persist, yet the potential for transformative medical breakthroughs presents lucrative opportunities.

Geographical Overview:

The single-cell analysis market is experiencing substantial growth across various regions, each presenting unique opportunities. North America leads the market due to advanced healthcare infrastructure and significant investments in genomics research. The presence of key industry players further enhances the region's position. Europe follows, driven by strong governmental support for research and development in biotechnology and personalized medicine. The Asia Pacific region is rapidly emerging, with countries like China and Japan at the forefront. Their investments in biotechnology and increasing healthcare expenditure are pivotal. These nations are also witnessing a surge in academic and research collaborations. Latin America and the Middle East & Africa are nascent markets with untapped potential. Brazil and South Africa are key players, focusing on improving healthcare infrastructure and research capabilities. These regions are also recognizing the importance of single-cell analysis in advancing precision medicine and genomic research, offering promising growth prospects.

Global tariffs and geopolitical tensions are profoundly influencing the Single-cell Analysis Market. In Japan and South Korea, trade frictions are encouraging investment in local biotechnological advancements to mitigate reliance on imports. China is accelerating its domestic R&D in single-cell technologies to counteract export restrictions, while Taiwan's strategic position in the semiconductor industry underpins its critical role in supply chains, despite geopolitical vulnerabilities. The parent market is experiencing robust growth, driven by increasing demand for precision medicine and personalized therapies globally. By 2035, the market is anticipated to evolve through enhanced regional collaborations and innovation in single-cell analytics. Meanwhile, Middle East conflicts may indirectly affect supply chains and energy prices, impacting operational costs and strategic planning in this high-growth sector.

Key Trends and Drivers:

The single-cell analysis market is experiencing remarkable growth, fueled by advancements in genomic technologies and personalized medicine. Key trends include the integration of artificial intelligence and machine learning, which enhance data analysis and interpretation, providing deeper insights into cellular behaviors. The demand for high-throughput sequencing technologies is also rising, enabling more comprehensive and cost-effective single-cell studies. Drivers of this market include the increasing prevalence of chronic diseases and the need for tailored therapeutic approaches. Researchers are focusing on understanding disease mechanisms at a cellular level, driving the adoption of single-cell analysis in oncology and immunology. Additionally, government funding and private investments are accelerating research and development activities, fostering innovation in this sector. The market is also witnessing a surge in collaborations between academic institutions and industry players, aiming to translate research findings into clinical applications. Opportunities are emerging in developing regions where healthcare infrastructure is improving, and research activities are expanding. Companies that offer scalable and user-friendly solutions are well-positioned to capture significant market share. The growing focus on precision medicine and early disease detection further underscores the potential for sustained growth in the single-cell analysis market.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Consumables
    • 4.1.2 Instruments
    • 4.1.3 Software
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Reagents
    • 4.2.2 Assay Kits
    • 4.2.3 Microplates
    • 4.2.4 Beads
    • 4.2.5 Instruments
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Cell Isolation
    • 4.3.2 Single-cell Genomics
    • 4.3.3 Single-cell Proteomics
    • 4.3.4 Single-cell Transcriptomics
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Flow Cytometry
    • 4.4.2 Mass Spectrometry
    • 4.4.3 Microscopy
    • 4.4.4 Next-generation Sequencing
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Cancer Research
    • 4.5.2 Neurology
    • 4.5.3 Immunology
    • 4.5.4 Stem Cell Research
    • 4.5.5 Microbiology
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Academic & Research Laboratories
    • 4.6.2 Biotechnology & Pharmaceutical Companies
    • 4.6.3 Hospitals & Diagnostic Laboratories
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Hardware
    • 4.7.2 Software
    • 4.7.3 Services
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Cell Viability Assessment
    • 4.8.2 Cell Identification
    • 4.8.3 Cell Counting
  • 4.9 Market Size & Forecast by Mode (2020-2035)
    • 4.9.1 Automated
    • 4.9.2 Manual

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Process
      • 5.2.1.9 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Process
      • 5.2.2.9 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Process
      • 5.2.3.9 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Process
      • 5.3.1.9 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Process
      • 5.3.2.9 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Process
      • 5.3.3.9 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Process
      • 5.4.1.9 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Process
      • 5.4.2.9 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Process
      • 5.4.3.9 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Process
      • 5.4.4.9 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Process
      • 5.4.5.9 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Process
      • 5.4.6.9 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Process
      • 5.4.7.9 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Process
      • 5.5.1.9 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Process
      • 5.5.2.9 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Process
      • 5.5.3.9 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Process
      • 5.5.4.9 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Process
      • 5.5.5.9 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Process
      • 5.5.6.9 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Process
      • 5.6.1.9 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Process
      • 5.6.2.9 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Process
      • 5.6.3.9 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Process
      • 5.6.4.9 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Process
      • 5.6.5.9 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Fluidigm
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 10x Genomics
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Mission Bio
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Bio- Rad Laboratories
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Takara Bio
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Nano String Technologies
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Illumina
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 BD Biosciences
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Berkeley Lights
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Cytek Biosciences
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 S2 Genomics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Epicypher
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Dolomite Bio
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Fluxion Biosciences
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Celsee
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Rare Cyte
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Akoya Biosciences
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Menarini Silicon Biosystems
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Parse Biosciences
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Proteona
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us